Adaptimmune Therapeutics Plc Stock Statistic Functions Beta
| ADAP Stock | USD 0.64 0.02 3.03% |
| Symbol |
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Adaptimmune Therapeutics correlated with the market. If Beta is less than 0 Adaptimmune Therapeutics generally moves in the opposite direction as compared to the market. If Adaptimmune Therapeutics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Adaptimmune Therapeutics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Adaptimmune Therapeutics is generally in the same direction as the market. If Beta > 1 Adaptimmune Therapeutics moves generally in the same direction as, but more than the movement of the benchmark.
Adaptimmune Therapeutics Technical Analysis Modules
Most technical analysis of Adaptimmune Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Adaptimmune from various momentum indicators to cycle indicators. When you analyze Adaptimmune charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Adaptimmune Therapeutics Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Adaptimmune Therapeutics Plc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Adaptimmune Therapeutics Plc based on widely used predictive technical indicators. In general, we focus on analyzing Adaptimmune Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Adaptimmune Therapeutics's daily price indicators and compare them against related drivers, such as statistic functions and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Adaptimmune Therapeutics's intrinsic value. In addition to deriving basic predictive indicators for Adaptimmune Therapeutics, we also check how macroeconomic factors affect Adaptimmune Therapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 13.69 | 26.87 | 1.21 | 1.15 | Days Of Inventory On Hand | 2.45 | 3.65 | 4.2 | 5.47 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Adaptimmune Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Adaptimmune Therapeutics' short interest history, or implied volatility extrapolated from Adaptimmune Therapeutics options trading.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Driverless Cars Invested over 200 shares | |
 | ESG Investing Invested few shares | |
 | Business Services Invested few shares | |
 | Banking Invested over 40 shares | |
 | Momentum Invested over 50 shares | |
 | Social Domain Invested few shares | |
 | Investor Favorites Invested few shares | |
 | Robots And Drones Sold few shares | |
 | Chemicals Invested over 30 shares | |
 | Baby Boomer Prospects Invested over 40 shares | |
Additional Tools for Adaptimmune Stock Analysis
When running Adaptimmune Therapeutics' price analysis, check to measure Adaptimmune Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adaptimmune Therapeutics is operating at the current time. Most of Adaptimmune Therapeutics' value examination focuses on studying past and present price action to predict the probability of Adaptimmune Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adaptimmune Therapeutics' price. Additionally, you may evaluate how the addition of Adaptimmune Therapeutics to your portfolios can decrease your overall portfolio volatility.